Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development

BACKGROUND: Over the past decade, human Interleukin 33 (hIL-33) has emerged as a key contributor to the pathogenesis of numerous inflammatory diseases. Despite the existence of several commercial hIL-33 assays spanning multiple platform technologies, their ability to provide accurate hIL-33 concentr...

Descripción completa

Detalles Bibliográficos
Autores principales: Mai, Elaine, Chan, Joyce, Goon, Levina, Ego, Braeden K., Bevers, Jack, Wong, Tiffany, Wong, Manda, Corpuz, Racquel, Xi, Hongkang, Wu, Jia, Schneider, Kellen, Seshasayee, Dhaya, Grimbaldeston, Michele, Nakamura, Gerald, Indjeian, Vahan B., van Lookeren Campagne, Menno, Loyet, Kelly M., Comps-Agrar, Laetitia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686655/
https://www.ncbi.nlm.nih.gov/pubmed/34930320
http://dx.doi.org/10.1186/s12967-021-03189-3

Ejemplares similares

Ejemplares similares